Hugo Harrod - Profile and Investment Details

Investor Profile

Hugo Harrod is a Venture Capital, Private Equity Firm, Investment Partner based in Greater London, England, United Kingdom with a diverse investment portfolio that includes companies such as SkyCell AG, AccuVein Inc., Vantia Therapeutics, Spherics, Onbone, Zipline Medical, SolxOxxon Therapeutics, Horizon Discovery, Clavis Pharma, Tarsa Therapeutics, GT Medical Technologies, Cara Therapeutics, SkyCell, Heptares Therapeutics, Providence Medical Technology, Vertos Medical, ProVerum, Serentis, Cheetah Medical, Biotheranostics, BioVex, De Novo Pharmaceuticals, Patient Connect, BioXell, Wilson Therapeutics, eXmoor Pharma, Vertos Medical Inc, Gynesonics, Inc., PregLem, Nalu Medical, Inc., Aegerion Pharmaceuticals, AmbioPharm, Lombard Medical plc, Vantia Ltd, Momenta Pharmaceuticals, Evotec Neurosciences, VitalConnect, Avantium Technologies, Xention, Neurent Medical, Paragon 28, eZono, Beacon Endoscopic, Vascular Pathways, MDxHealth, AccuVein, eZono AG, . Over time, Hugo Harrod has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Hugo Harrod is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, High-growth Startups, Wellness, Women Founded, Fundraising, Investment Management, HR Tech, Android, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Analytics, Venture Fundraising, Finance, Intellectual Property, Manufacturing, Biotechnology, Medical Devices, Hardware, Logistics, Health Diagnostics, Digital Health, Developer Tools, Medical, Information Technology, B2B, Media and Entertainment, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Hugo Harrod, as their portfolio suggests a familiarity and interest in this area.

Understanding Hugo Harrod’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.